Testosterone

There are 1,205 papers on testosterone in aging research: 270 trials and 395 observational studies in people, 233 in animals, 13 in cells, 276 reviews. The newest story, Nov 9, 2026: “DNA variants relevant to menopause show varied health links”.

Biomarker

1,205 papers study it1,076 more mention it523 findings

MeSH

69 new papers in 30 daysSee all 2,281 papers on testosterone

At a glance

Testosterone is associated with mortality, bone density and lean mass in human cohorts of men. A longitudinal study links increasing age with declining levels in healthy men. Human trials report increases with exercise, whereas a trial in women with polycystic ovary syndrome reports a decrease.

523 findings in 417 papers from 1978 to 2026, 64 of them since April 2026

“Changes in 6MWT distance were significantly associated with changes in testosterone, free testosterone, dihydrotestosterone, and haemoglobin concentrations”
Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone TrialsThe lancet. Diabetes & endocrinology2018doi:10.1016/s2213-8587(18)30171-2
  • Human trial270
  • Humans395
  • Animals231
  • Model organisms2
  • Cells13
  • In silico1

Interventions

130

Dehydroepiandrosterone

upin humans15no changein humans3upin human cells1upin mice1+1+192% above basal levels

20 studies
  1. Dehydroepiandrosterone increases testosterone in humans.

    “The change from baseline to 12 weeks in estrone and testosterone (total and free) concentrations also significantly differed from PM for both doses of DHEA.”

    Human trial12 weeksfemalesn = 345

    Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

  2. Dehydroepiandrosterone showed no clear effect on testosterone in women with vulvovaginal atrophy.

    “No significant change from baseline of average 24h serum E2 or testosterone concentrations was observed.”

    Human trialin women with vulvovaginal atrophyintravaginalserum6.5mgfemales

    Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens

    The Journal of steroid biochemistry and molecular biology

  3. Dehydroepiandrosterone increases testosterone in humans (versus placebo, randomized crossover).

    “Under DHEA, testosterone and estradiol levels were increased in all individuals.”

    Human trialversus placebo, randomized crossoveroral capsule50 mg daily3 weeksfemalesn = 7

    Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study

    Clinical endocrinology

  4. Dehydroepiandrosterone increases testosterone in postmenopausal women with hypoactive sexual desire disorder.

    “while bioavailable testosterone levels increased in women only.”

    Human trialin postmenopausal women with hypoactive sexual desire disorder100 mg daily6 weeksfemalesn = 27

    The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences

    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

  5. Dehydroepiandrosterone increases testosterone in humans (at 2.0% DHEA dose) (+192% above basal levels).

    “serum testosterone and dihydrosterone were increased by 192% and 275%, respectively, above basal levels”

    Human trialat 2.0% DHEA dosecreamserum3g of 2.0% DHEA cream twice dailyfemalesn = 75

    Metabolism of DHEA in postmenopausal women following percutaneous administration

    The Journal of steroid biochemistry and molecular biology

  6. Dehydroepiandrosterone increases testosterone in humans (compared with baseline; placebo group unchanged) (23.6 ± 1.0 vs 17.7 ± 1.0 nmol/l).

    “This effect is coupled with a decrease in PAI-1 and LDL cholesterol levels as well as an increase in testosterone and E(2) levels.”

    Human trialcompared with baseline; placebo group unchanged50 mg daily at bedtime2 monthsmalesn = 24

    Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects

    Clinical endocrinology

  7. Dehydroepiandrosterone increases testosterone in humans.

    “Significant increases in mean DHEA, DHEA sulfate (DHEA-S), testosterone, and androstenedione levels were noted with DHEA alone or combined DHEA/CEE treatments when compared with placebo.”

    Human trial50 mg daily12-weekfemales

    Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids

    Journal of women's health (2002)

  8. Dehydroepiandrosterone increases testosterone in humans (hypoadrenal women).

    “DHEA replacement significantly increased DHEA-S (sulfated ester of DHEA), bioavailable testosterone, and androstenedione”

    Human trialhypoadrenal women50-mg12 weeksfemalesn = 28

    Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women

    Diabetes

  9. Dehydroepiandrosterone increases testosterone in humans (hypoadrenalism) (from 0.4+/-0.1 to 1.45+/-0.26 nmol/l).

    “Only in hypoadrenal women an increase in testosterone (T; from 0.4+/-0.1 to 1.45+/-0.26 nmol/l, p<0.05)”

    Human trialhypoadrenalism50 mg/day4 monthsfemales

    Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism

    Journal of endocrinological investigation

  10. Dehydroepiandrosterone increases testosterone in humans (very low serum DHEAS levels) (Men: 10.7 +/- 1.2 to 15.6 +/- 1.8 nmol/l; women: 2.1 +/- 0.2 to 4.5 +/- 0.4 nmol/l).

    “and total serum testosterone concentrations (from 10.7 +/- 1.2 to 15.6 +/- 1.8 nmol/l in the men”

    Human trialvery low serum DHEAS levelsserum50 mg/day6 months

    Effects of DHEA replacement on bone mineral density and body composition in elderly women and men

    Clinical endocrinology

All 21

More on Dehydroepiandrosterone

Testosterone

upin humans12

12 studies
  1. Testosterone increases testosterone in humans (post-menopausal women with HSDD on estrogen-containing HRT) (unadjusted median Cmax 6.25 nmol/L, Cavg 4.51 nmol/L).

    “The unadjusted median Cmax testosterone concentration was 6.25 nmol/L (range 1.3-26.1), and Cavg was 4.51 nmol/L (range 0.93-20.21).”

    Human trialpost-menopausal women with HSDD on estrogen-containing HRT16.2 mg/g gel via pumpserum20.25 mgfemalesn = 24

    A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post-Menopausal Women With Hypoactive Sexual Desire Disorder (HSSD) Already Receiving This as Part of Usual Care in Conjunction With Oestrogen-Containing Hormone Replacement Treatment (HRT)

    Clinical endocrinology

  2. Testosterone increases testosterone in humans (late-onset hypogonadism).

    “Compared with the baseline values of serum testosterone, those following NTG and AF2 treatment were significantly higher”

    Human triallate-onset hypogonadismgel4 weeksmalesn = 23

    Novel testosterone gel improves serum testosterone concentrations and aging males' symptoms in patients with late-onset hypogonadism: an active control equivalence, randomized, double-blind, crossover study

    Endocrine journal

  3. Testosterone increases testosterone in humans during androgen deprivation therapy (∆ 2.2 (1.3-3.0) vs -0.7 (-1.5 to 0.2) nmol/L; P < 0.01).

    “Mean (95% CI) testosterone rose during LTTT but not placebo treatment [∆ 2.2 (1.3-3.0) vs -0.7 (-1.5 to 0.2) nmol/L; P < 0.01].”

    Human trialduring androgen deprivation therapyoral40 mg/day6 monthsmalesn = 42

    A Novel Liver-targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men With Prostate Cancer

    Journal of the Endocrine Society

  4. Testosterone increases testosterone in humans (testosterone-deficient chronic heart failure with reduced ejection fraction) (P = .002).

    “testosterone replacement increased testosterone levels ( P = .002)”

    Human trialtestosterone-deficient chronic heart failure with reduced ejection fractiontestosterone undecanoate1000 mg12 monthsmalesn = 29

    Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study

    Journal of cardiovascular pharmacology and therapeutics

  5. Testosterone increases testosterone in humans (addition of transdermal testosterone to EPT).

    “Significant differences were found in serum total testosterone levels among women with POI receiving T treatment, compared with placebo after three months and at 12 months (P < 0.001 for both groups at each time interval respectively).”

    Human trialaddition of transdermal testosterone to EPTone yearfemalesn = 128

    Effects of physiologic testosterone therapy on quality of life, self-esteem, and mood in women with primary ovarian insufficiency

    Menopause (New York, N.Y.)

  6. Testosterone increases testosterone in humans (augmentation of standard estrogen/progestin therapy) (P < 0.001).

    “Serum testosterone levels achieved physiologic levels in the testosterone group and were significantly higher compared with placebo (P < 0.001).”

    Human trialaugmentation of standard estrogen/progestin therapy150-μg patch12 monthsfemalesn = 128

    Effects of physiologic testosterone therapy on quality of life, self-esteem, and mood in women with primary ovarian insufficiency

    Menopause (New York, N.Y.)

  7. Testosterone increases testosterone in humans (acquired hypogonadism) (from 2.01+/-1.04 to 4.68+/-2.43 and 7.83+/-6.2 nmol/l, P=0.001).

    “Testosterone therapy increased BT level from 2.01+/-1.04 to 4.68+/-2.43 and 7.83+/-6.2 nmol/l after 48 h and 3 months respectively (P=0.001).”

    Human trialacquired hypogonadismtransdermal90 daysmalesn = 18

    Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men

    European journal of endocrinology

  8. Testosterone increases testosterone in humans (late-onset hypogonadism with LUTS).

    “plasma testosterone increased to the normal range”

    Human triallate-onset hypogonadism with LUTSmales

    Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study

    The aging male : the official journal of the International Society for the Study of the Aging Male

  9. Testosterone increases testosterone in humans (elderly men with relative testosterone insufficiency) (10.0 +/- 1.9 nmol/l in Group 1, 6.6 +/- 1.6 nmol/l in Group 2).

    “Serum testosterone increased by a mean of 10.0 +/- 1.9, 6.6 +/- 1.6, 0.52 +/- 0.6, and 0.5 +/- 0.6 nmol/l in Groups 1, 2, 3, and 4 respectively.”

    Human trialelderly men with relative testosterone insufficiency12 weeksmalesn = 70

    Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men

    European journal of endocrinology

  10. Testosterone increases testosterone in humans (from 0.87 +/- 0.06 to 5 +/- 1 and 7.3 +/- 1.6 nmol/l).

    “Graded Te supplementation increased serum Te concentrations (nmol/l) from 0.87 +/- 0.06 [Pl] to 5 +/- 1 [low] and 7.3 +/- 1.6 [high] (P < 0.001)”

    Human trial7 daysfemalesn = 15

    Short-term testosterone supplementation does not activate GH and IGF-I production in postmenopausal women

    Clinical endocrinology

All 13

More on Testosterone

Exercise

upin humans7downin humans3upin chickens1upin rats1

12 studies
  1. Exercise decreases testosterone in humans (polycystic ovary syndrome).

    “exercise significantly reduced total testosterone (TT), free testosterone, fasting insulin, and homeostatic model assessment of insulin resistance (HOMA-IR)”

    Human trialpolycystic ovary syndromefemales

    The Effect of Exercise on Reproductive and Metabolic Outcomes in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

    The journal of obstetrics and gynaecology research

  2. Exercise increases testosterone in humans.

    “In men, a significant Time × Group interaction was observed for total testosterone (F = 4.21, p = 0.050, ηp2 = 0.135).”

    Human trial12 weeks

    Combined Aerobic and Resistance Exercise Program in Adults: Endocrine and Metabolic Adaptations

    Life (Basel, Switzerland)

  3. Exercise decreases testosterone in patients with polycystic ovary syndrome (g = -0.34, 95% CI [-0.61 to -0.07]).

    “Exercise interventions significantly lowered testosterone levels (g = -0.34; 95% CI [-0.61 to -0.07]; P = 0.0146).”

    Human trialin patients with polycystic ovary syndromeserumfemalesn = 1,018

    Effects of exercise on reproductive endocrine hormones in adult patients with polycystic ovary syndrome: a systematic review and three-level meta-analysis

    PeerJ

  4. Exercise increases testosterone in humans.

    “GH22kD, TES, and COR elevated significantly in all loadings measured in the afternoon in MID.”

    Human trialmalesn = 27

    Acute Neuromuscular and Hormonal Responses to Different Exercise Loadings Followed by a Sauna

    Journal of strength and conditioning research

  5. Exercise increases testosterone in humans.

    “The combination of exercise and TRT showed significant improvements in serum T levels and LOH symptoms compared to TRT alone.”

    Human trial20 weeksmalesn = 50

    Exercise improves the effects of testosterone replacement therapy and the durability of response after cessation of treatment: a pilot randomized controlled trial

    Asian journal of andrology

  6. Exercise increases testosterone in humans (relative to sedentary subjects).

    “Exercise also increased testosterone levels relative to sedentary subjects.”

    Human trialrelative to sedentary subjects4 weeks

    Effects of magnesium supplementation on testosterone levels of athletes and sedentary subjects at rest and after exhaustion

    Biological trace element research

  7. Exercise is linked with higher testosterone in humans (compared to untrained age-matched controls) (p < 0.05).

    “The MAC group had lower testosterone levels compared to the YC and EMA group (p < 0.05)”

    Humanscompared to untrained age-matched controlsvenous bloodmales

    Relationship between inflammatory biomarkers and testosterone levels in male master athletes and non-athletes

    Experimental gerontology

  8. Exercise increases testosterone in chickens.

    “increased serum levels of testosterone and gonadotropins”

    Animals4-weekmalesn = 36

    Sport improves function of roosters testicular Leydig cells by mediating FUNDC1

    Poultry science

  9. Exercise decreases testosterone in humans (extended high-intensity exercise recovery) (up to 72 h).

    “extended high-intensity exercise causes testosterone suppression during recovery due to cortisol antagonism for up to 72 h.”

    Reviewextended high-intensity exercise recovery

    Effect of acute exercise on the dynamics of testosterone levels: a systematic review of randomized controlled trials

    PeerJ

  10. Exercise increases testosterone in older adults.

    “Specific training modalities may attenuate or reverse parts of this decline, increasing serum concentrations of hormones like testosterone (ZOUHAL et al., 2022) and growth hormone”

    Reviewin older adults

    Endocrine Responses to Physical Exercise in Older Adults: A Scoping Review of Hormonal Axes and Training Variables

    Preprint

All 12

More on Exercise

Caloric restriction

upin rats4downin rats3downin chickens1no changein humans1+2

11 studies
  1. Caloric restriction showed no clear effect on testosterone in humans (WMD: -0.02 ng/mL, 95% CI: -0.13 to 0.08, p = 0.65).

    “CR had a non-significant effect on testosterone (WMD: -0.02 ng/mL; 95% CI: -0.13 to 0.08; p = 0.65)”

    Review

    The Effects of Fasting and Caloric Restriction on Reproductive Hormones: A Systematic Review, Meta-Analysis, and GRADE Assessment

    Food science & nutrition

  2. Caloric restriction decreases testosterone in rats.

    “LTDR additionally decreased T synthesis, expression of Star/StAR and Cyp11a1/CYP11A1, and testicular CHOL levels.”

    Animalsserum18 monthsmales

    Long-term dietary restriction changes lipid homeostasis and consequently impairs testosterone production in aged Wistar rats

    Frontiers in nutrition

  3. Caloric restriction increases testosterone in men with or without obesity.

    “Clinical studies, such as CALERIE, have shown an improvement in serum testosterone level and sexual drive in men with or without obesity.”

    Reviewin men with or without obesitymales

    Effects of Calorie Restriction on Preserving Male Fertility Particularly in a State of Obesity

    Current obesity reports

  4. Caloric restriction increases testosterone in rats (compared with controls).

    “improved after 6 months of CR associated with increases in plasma testosterone”

    Animalscompared with controlsplasma15% or 35% caloric restriction6 monthsmales

    Effect of Chronic Moderate Caloric Restriction on the Reproductive Function in Aged Male Wistar Rats

    Nutrients

  5. Caloric restriction decreases testosterone in rats.

    “CR decreased both T and CORT in the blood and brain.”

    Animalsblood and brain2 or 6 weeksmales

    Testosterone and Corticosterone in the Mesocorticolimbic System of Male Rats: Effects of Gonadectomy and Caloric Restriction

    Endocrinology

  6. Caloric restriction increases testosterone in rats.

    “CR also increased serum testosterone level in aged rats, but not in young rats”

    Animalsserum6 weeks

    Calorie restriction reverses age-related alteration of cavernous neurovascular structure in the rat

    Andrology

  7. Caloric restriction decreases testosterone in chickens (basal).

    “reduced output of T”

    Animalsbasalovarian fragments

    The role of metabolic state and obestatin in control of chicken ovarian hormone release

    Poultry science

  8. Caloric restriction decreases testosterone in rats.

    “A dose-response was also observed for serum testosterone, with higher doses of CR associated with lower testosterone.”

    Animals3 weeks

    Calorie restriction at increasing levels leads to augmented concentrations of corticosterone and decreasing concentrations of testosterone in rats

    Nutrition research (New York, N.Y.)

  9. Caloric restriction showed no clear effect on testosterone in mutant mice with altered GH signaling and control mice.

    “Mild CR did not affect testosterone levels in testis homogenates”

    Animalsin mutant mice with altered GH signaling and control mice20% reduction of calorie intaketestismales

    Mild calorie restriction does not affect testosterone levels and testicular gene expression in mutant mice

    Experimental biology and medicine (Maywood, N.J.)

  10. Caloric restriction increases testosterone in Lobund-Wistar rats.

    “Testosterone levels declined significantly with age in all rats, but were significantly higher in restricted rats at all ages.”

    Animalsin Lobund-Wistar rats12 grams (70% of ad libitum) of diet per day

    Serum hormones in diet-restricted gnotobiotic and conventional Lobund-Wistar rats

    Journal of gerontology

All 11

More on Caloric restriction

Resistance training

upin humans5no changein humans3

8 studies
  1. Resistance training increases testosterone in humans (Healthy runners; compared with baseline).

    “Both training groups showed significant increases in serum testosterone (p < 0.001), IGF-1 (p < 0.001), cortisol (p < 0.001), T/C ratio (p < 0.001)”

    Human trialHealthy runners; compared with baselinehigh-loadSeven exercises, three sets at 70–85% 1RM to failure12 weeksmalesn = 15

    12-Week Resistance Training and Detraining: Hormonal, Structural and Functional Adaptations to Two Protocols in Male Runners Running title: Adaptation to resistance training and detraining

    Research SquarePreprint

  2. Resistance training showed no clear effect on testosterone in humans.

    “There were no significant changes in basal hormone levels or changes from basal to immediately post exercise (p > 0.059).”

    Human trial9 weeksmalesn = 17

    Muscle Hypertrophy, Strength, and Salivary Hormone Changes Following 9 Weeks of High- or Low-Load Resistance Training

    Journal of functional morphology and kinesiology

  3. Resistance training showed no clear effect on testosterone in humans (sarcopenia).

    “No change over time was found for IGF-1 and testosterone (p > 0.05).”

    Human trialsarcopenia12 weeksfemalesn = 34

    Effects of Different Resistance Training Frequencies on Body Composition, Muscular Strength, Muscle Quality, and Metabolic Biomarkers in Sarcopenic Older Women

    Journal of strength and conditioning research

  4. Resistance training increases testosterone in the afternoon subject group in MID.

    “Significant elevations in TES took place in the afternoon subject group in MID in all the exercise loadings (Figure 2 and Table 3).”

    Human trialin the afternoon subject group in MID32 minutes

    Acute Neuromuscular and Hormonal Responses to Different Exercise Loadings Followed by a Sauna

    Journal of strength and conditioning research

  5. Resistance training increases testosterone in both healthy and sarcopenic men.

    “Follistatin and testosterone increased in the healthy group; in contrast, only testosterone increased in the sarcopenic group after training (P < 0.05).”

    Human trialin both healthy and sarcopenic men8 weeksmales

    Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-body Resistance Training

    International journal of preventive medicine

  6. Resistance training showed no clear effect on testosterone in humans.

    “There were no significant (p > 0.05) main effects for IGF-1 and testosterone.”

    Human trial8 weeksfemalesn = 25

    Effects of Traditional and Pyramidal Resistance Training Systems on Muscular Strength, Muscle Mass, and Hormonal Responses in Older Women: A Randomized Crossover Trial

    Journal of strength and conditioning research

  7. Resistance training increases testosterone in humans (functional/obesity-related cases).

    “weight loss and resistance training, which can restore endogenous testosterone in functional/obesity-related cases”

    Reviewfunctional/obesity-related cases

    Late-onset Hypogonadism: Current perspective on diagnosis, management and impact on healthy aging

    Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh

  8. Resistance training increases testosterone in humans.

    “Testosterone levels demonstrate a greater increase following resistance training, with a delayed return to baseline levels”

    Review

    Effect of acute exercise on the dynamics of testosterone levels: a systematic review of randomized controlled trials

    PeerJ

More on Resistance training

Ashwagandha

upin humans4no changein humans1+15%

5 studies
  1. Ashwagandha showed no clear effect on testosterone in humans (perimenopause).

    “There was no significant between the group differences in the serum testosterone level.”

    Human trialperimenopauseserum300 mg twice daily8-weekfemalesn = 91

    Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study

    The journal of obstetrics and gynaecology research

  2. Ashwagandha increases testosterone in humans (+14.7%).

    “The 2 × 2 crossover, two-sample t-test confirmed significantly higher levels of DHEA-S (T37 = 2.97, p =.005) and testosterone (T36 = 2.74, p =.010) during ashwagandha intake, compared to placebo intake (18.0% and 14.7%, respectively).”

    Human trial16 weeks

    A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males

    American journal of men's health

  3. Ashwagandha increases testosterone in humans (overweight males with mild fatigue) (14.7% greater increase, p = .010).

    “14.7% greater increase in testosterone ( p = .010) compared to the placebo”

    Human trialoverweight males with mild fatigueShoden beadssaliva21 mg of withanolide glycosides a day8 weeksmalesn = 50

    A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males

    American journal of men's health

  4. Ashwagandha increases testosterone in humans (undergoing weight training) (Placebo: 18.00 ng/dL vs. Ashwagandha: 96.19 ng/dL).

    “The increase in testosterone level was significantly greater with ashwagandha supplementation than with the placebo (Placebo: 18.00 ng/dL, 95 % CI, -15.83, 51.82 vs. Ashwagandha: 96.19 ng/dL, 95 % CI, 54.86, 137.53; p = 0.004).”

    Human trialundergoing weight training8 weeksmalesn = 57

    Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial

    Journal of the International Society of Sports Nutrition

  5. Ashwagandha increases testosterone in humans (engaged in resistance training) (96.2 ng/dL (95% CI 54.7, 137.5) vs 18.0 ng/dL (95% CI -15.8, 51.8), p = 0.004).

    “significantly greater increase in testosterone level (Placebo: 18.0 ng/dL, 95% CI, -15.8, 51.8 vs. Ashwagandha: 96.2 ng/dL, 95% CI, 54.7, 137.5; p = 0.004)”

    Human trialengaged in resistance trainingroot extract300 mg twice daily8 weeksmalesn = 57

    Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial

    Journal of the International Society of Sports Nutrition

  6. Ashwagandha increases testosterone in humans.

    “adaptogenic herbs, particularly ashwagandha, support testosterone levels by modulating cortisol and promoting testicular health”

    Reviewmales

    Integrative Natural Approaches for Age-Related Testosterone Decline: A Synergistic Framework Combining Exercise, Nutrition, and Bioactive Compounds

    Cureus

  7. Ashwagandha increases testosterone in humans.

    “notably increasing testosterone levels in men”

    Reviewmales

    Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)

    Phytotherapy research : PTR

More on Ashwagandha

Aerobic exercise

downin humans3upin humans1

4 studies
  1. Aerobic exercise decreases testosterone in patients with polycystic ovary syndrome (g = -0.5120, 95% CI [-0.8230 to -0.2010]).

    “Subgroup analysis revealed that the "aerobic exercise" group was statistically significant (k = 14, g = -0.5120, 95% CI [-0.8230 to -0.2010], P = 0.0027).”

    Human trialin patients with polycystic ovary syndromeserumfemales

    Effects of exercise on reproductive endocrine hormones in adult patients with polycystic ovary syndrome: a systematic review and three-level meta-analysis

    PeerJ

  2. Aerobic exercise decreases testosterone in women with PCOS.

    “The testosterone level decreased after CAT (p ≤ 0.001) and IAT (p = 0.019) and the FAI was reduced only in the IAT group (p = 0.037).”

    Human trialin women with PCOS16 weeks

    Short-Term Aerobic Exercise Did Not Change Telomere Length While It Reduced Testosterone Levels and Obesity Indexes in PCOS: A Randomized Controlled Clinical Trial Study

    International journal of environmental research and public health

  3. Aerobic exercise decreases testosterone in PCOS women (CAT, p <= 0.001; IAT, p = 0.019).

    “The hyper-andro-genism measured by testosterone levels was reduced after both exercises (CAT, p ≤ 0.001; IAT, p = 0.019).”

    Human trialin PCOS women16 weeksfemales

    Short-Term Aerobic Exercise Did Not Change Telomere Length While It Reduced Testosterone Levels and Obesity Indexes in PCOS: A Randomized Controlled Clinical Trial Study

    International journal of environmental research and public health

  4. Aerobic exercise increases testosterone in humans (high physical activity).

    “After the 12-week intervention, serum testosterone levels significantly increased only in the HPA group but not in the LPA group.”

    Human trialhigh physical activity12 weeksn = 21

    Increased physical activity has a greater effect than reduced energy intake on lifestyle modification-induced increases in testosterone

    Journal of clinical biochemistry and nutrition

  5. Aerobic exercise decreases testosterone in humans (polyendocrine metabolic ovarian syndrome) (Hedges' g = -0.45, 95% CI: -0.62 to -0.30).

    “Compared with control groups, aerobic exercise reduced testosterone”

    Reviewpolyendocrine metabolic ovarian syndromefemales

    Effects of aerobic exercise on reproductive hormone profiles in women with polyendocrine metabolic ovarian syndrome (polycystic ovary syndrome): a meta-analysis

    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

More on Aerobic exercise

Sildenafil

upin rats4

4 studies
  1. Sildenafil increases testosterone in rats.

    “Long-term sildenafil treatment increased locomotor activity, testosterone, and sperm number, while corticosterone tended to decrease.”

    Animalslow-doseFrom 12 to 18 months of agemales

    Long-term sildenafil attenuates age-associated functional and reproductive decline in male rats

    Reproduction (Cambridge, England)

  2. Sildenafil increases testosterone in rats (aged rats).

    “significant increase in serum levels of E2 and T, as well as T in dorsal lobe prostate tissue of aged rats, were observed”

    Animalsaged ratsdorsal lobe prostate tissuemales

    Sildenafil citrate induces prostatic hyperplasia in BPH model rats and aged rats

    Toxicology and applied pharmacology

  3. Sildenafil increases testosterone in rats (acute in vivo PDE5 inhibition).

    “Acute in vivo PDE5 inhibition overaccumulated cGMP and stimulated testosterone but reduced ATP production in Leydig cells from adult, middle-aged, and old rats”

    Animalsacute in vivo PDE5 inhibitionLeydig cellsacute

    Aging-Related Increase of cGMP Disrupts Mitochondrial Homeostasis in Leydig Cells

    The journals of gerontology. Series A, Biological sciences and medical sciences

  4. Sildenafil increases testosterone in rats.

    “a long-term treatment with sildenafil (PDE5 inhibitor) normalized testosterone/nitrite levels in circulation and cGMP accumulation in TIF”

    Animalslong-term

    Long-term inhibition of PDE5 ameliorates aging-induced changes in rat testis

    Experimental gerontology

More on Sildenafil

Resveratrol

upin mice2downin humans1no changein rats1

4 studies
  1. Resveratrol decreases testosterone in humans (PCOS) (-23.1% (P = .01)).

    “Resveratrol treatment led to a significant decrease of total T by 23.1% (P = .01).”

    Human trialPCOSoral1,500 mg daily3 monthsfemalesn = 30

    Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial

    The Journal of clinical endocrinology and metabolism

  2. Resveratrol increases testosterone in Cd-exposed mice.

    “mice treated with resveratrol (50 mg/kg), a specific SIRT1 activator, mitigated Leydig cell senescence and reversed Cd-reduced testosterone levels in mouse testes.”

    Animalsin Cd-exposed micetestes50 mg/kg

    Sirt1 m6A modification-evoked Leydig cell senescence promotes Cd-induced testosterone decline

    Ecotoxicology and environmental safety

  3. Resveratrol increases testosterone in mice.

    “Results found that RSV supplement increased testosterone production in both aged mice and D-galactose-induced senescent Leydig cells.”

    Animalsdiet supplementtestis16 monthsmales

    Autophagy-related 7 proteindependent autophagy mediates resveratrol-caused upregulation of mitochondrial biogenesis and steroidogenesis in aged Leydig cell

    Molecular biology reports

  4. Resveratrol showed no clear effect on testosterone in rats (Age-related decline; compared with control and vehicle-treated rats).

    “drop of plasma testosterone in control and vehicle-treated male rats, whose pattern remained unaffected by MEL and RSV treatment.”

    AnimalsAge-related decline; compared with control and vehicle-treated ratsplasma10 mg/L; estimated 300-400 μg/kg body mass daily9 or 21 monthsmales

    Long-term effects of melatonin and resveratrol on aging rats: A multi-biomarker approach

    Mutation research. Genetic toxicology and environmental mutagenesis

More on Resveratrol

Quercetin

downin humans3downin reviews1

4 studies
  1. Quercetin decreases testosterone in humans (overweight or obese women with polycystic ovary syndrome) (0.72 ± 0.15 vs. 0.76 ± 0.12 ng/ml, p = 0.001).

    “testosterone (0.72 ± 0.15 vs. 0.76 ± 0.12 ng/ml, p = 0.001) and LH (8.05 ± 2.88 vs. 8.77 ± 1.99 mIU/ml, p = 0.035) concentrations were significantly lower in quercetin”

    Human trialoverweight or obese women with polycystic ovary syndromecirculatory1,000 mg/day12 weeksfemalesn = 78

    The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome

    Phytotherapy research : PTR

  2. Quercetin decreases testosterone in humans (polycystic ovary syndrome) (0.71 ng/dl in quercetin vs. 0.77 ng/dl in placebo).

    “while it reduced the level of testosterone (0.71 ng/dl in quercetin vs. 0.77 ng/dl in placebo; p<0.001) and LH (8.42 IU/l in quercetin vs. 8.68 IU/l in placebo; p=0.009).”

    Human trialpolycystic ovary syndrome1 g daily12 weeksfemalesn = 84

    Effects of Quercetin on Adiponectin-Mediated Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Double-Blind Clinical Trial

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

  3. Quercetin decreases testosterone in PCOS patients.

    “serum testosterone (T), luteinizing hormone (LH), the LH/follicule-stimulating hormone (FSH) ratio, fasting glucose, fasting insulin, HOMA-IR and lipid levels are reduced in PCOS patients with QUR treatment”

    Reviewin PCOS patients

    Quercetin and polycystic ovary syndrome

    Frontiers in pharmacology

  4. Quercetin decreases testosterone in subjects with PCOS.

    “The effects of quercetin on reducing the levels of testosterone, luteinizing hormone (LH), and insulin resistance were also reported.”

    Reviewin subjects with PCOS

    Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review

    Journal of ovarian research

More on Quercetin

Intermittent fasting

no changein humans1downin humans1downin reviews1

3 studies
  1. Intermittent fasting showed no clear effect on testosterone in humans (obese males undergoing resistance training).

    “The testosterone levels and muscle strength improved with RT, and there was no difference between the C/RT and IF/RT groups.”

    Human trialobese males undergoing resistance training8 weeksmalesn = 20

    Intermittent Fasting May Enhance Resistance Training Effects on the Body Composition of Obese Males, Without Affecting Muscular Strength and Anabolic Index

    Journal of obesity

  2. Intermittent fasting decreases testosterone.

    “IF may modestly reduce testosterone in men without impairing muscle mass or strength”

    Reviewmales

    Sexual Dimorphism and Menopausal Transition: A Narrative Review of the Metabolic and Physical Effects of Intermittent Fasting

    Nutrients

  3. Intermittent fasting decreases testosterone in women with PCOS (MD -13.4 ng/dL, 95% CI -18.1 to -8.7).

    “reductions in serum testosterone levels (mean difference [MD] −13.4 ng/dL; 95% CI, −18.1 to −8.7)”

    Reviewin women with PCOS

    SAT-514 The Metabolic And Endocrine Effects Of Intermittent Fasting In Women With PCOS: A Meta-analysis Of Randomized Trials

    ENDO 2025 abstract

More on Intermittent fasting

Time-restricted feeding

no changein humans1no changein rats1

2 studies
  1. Time-restricted feeding showed no clear effect on testosterone in humans (Premenopausal and postmenopausal females with obesity; before-and-after comparison).

    “Circulating levels of testosterone, androstenedione, and sex hormone binding globulin (SHBG) did not change in either group”

    Human trialPremenopausal and postmenopausal females with obesity; before-and-after comparison4- to 6-hour eating window8 weeksfemales

    Effect of time-restricted eating on sex hormone levels in premenopausal and postmenopausal females

    Obesity (Silver Spring, Md.)

  2. Time-restricted feeding showed no clear effect on testosterone in rats (alone or in combination).

    “neither IF nor PT, alone or in combination, resulted in improvements in testosterone levels or AR expression in the gastrocnemius muscle. with testosterone levels remained unchanged.”

    Animalsalone or in combinationgastrocnemius muscle8 weeksmales

    Effects of time-restricted feeding and weight-loaded swimming test on androgen levels and androgen receptor expression in orchiectomized male Wistar rats

    Clinical nutrition ESPEN

More on Time-restricted feeding

Limosilactobacillus reuteri

no changein humans1upin mice1

2 studies
  1. Limosilactobacillus reuteri showed no clear effect on testosterone in humans (well within the reference intervals given for the age group).

    “In our case all study participants are well within the reference intervals given for the age group for the investigated parameters e.g., testosterone, SHGB, LH and FSH and thereby not considered deficient in these parameters.”

    Human trialwell within the reference intervals given for the age group12 weeksmalesn = 49

    Effects of probiotic supplementation on testosterone levels in healthy ageing men: A 12-week double-blind, placebo-controlled randomized clinical trial

    Contemporary clinical trials communications

  2. Limosilactobacillus reuteri increases testosterone in mice.

    “males treated with anti-inflammatory BM36301 experienced less weight gain and higher testosterone level”

    Animalsin drinking water20 weeksmales

    Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice

    BMC microbiology

More on Limosilactobacillus reuteri

Coenzyme Q10

downin humans2

2 studies
  1. Coenzyme Q10 decreases testosterone in humans (PCOS) (P < 0.001).

    “CoQ10, vitamin E, and cosupplementation led to decreased serum total testosterone levels (P < 0.001) compared with those of the placebo group.”

    Human trialPCOS8 weeksfemalesn = 86

    Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome

    The Journal of clinical endocrinology and metabolism

  2. Coenzyme Q10 decreases testosterone in humans (polycystic ovary syndrome) (SMD -0.28 [-0.49, -0.06], P = 0.01).

    “testosterone (SMD - 0.28 [- 0.49, - 0.06], P = 0.01)”

    Reviewpolycystic ovary syndrome

    Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis

    Reproductive sciences (Thousand Oaks, Calif.)

More on Coenzyme Q10

Lacticaseibacillus paracasei

upin humans1

1 study
  1. Lacticaseibacillus paracasei increases testosterone in humans.

    “Testosterone levels were also significantly higher in the HT-PS23 group than in the placebo group after 6 and 12 weeks of supplementation (p = 0.035 each).”

    Human trial12 weeks

    Enhancement of Lower Limb Muscle Strength and Reduction of Inflammation in the Elderly: A Randomized, Double-Blind Clinical Trial Comparing Lacticaseibacillus paracasei PS23 Probiotic with Heat-Treated Supplementation

    Nutrients

  2. Lacticaseibacillus paracasei increases testosterone in humans (p = 0.029).

    “Notably, only the HT-PS23 group demonstrated a significant increase in testosterone levels (p = 0.029).”

    Human trialheat-treated PS2312 weeks

    Enhancement of Lower Limb Muscle Strength and Reduction of Inflammation in the Elderly: A Randomized, Double-Blind Clinical Trial Comparing Lacticaseibacillus paracasei PS23 Probiotic with Heat-Treated Supplementation

    Nutrients

More on Lacticaseibacillus paracasei

All 130

Effects

39

Cognitive function

no changein humans4OR 0.96

4 studies
  1. Testosterone was not clearly linked with cognitive function in humans (OR 0.96, 95% CI 0.63 to 1.49, p = 0.86).

    “154 women (39%) had a decline in blood testosterone which was not associated with a decline in any cognitive measure”

    Humansblood3 yearsfemalesn = 395

    Associations between declining testosterone concentrations and cognitive performance in community-dwelling older Australian women: a prospective cohort study

    Climacteric : the journal of the International Menopause Society

  2. Testosterone was not clearly linked with cognitive function in humans (type 2 diabetes).

    “Total testosterone levels were not associated with cognitive function in women”

    Humanstype 2 diabetesserumfemales

    Associations between cognitive function and endogenous levels of estradiol and testosterone in adults with type 2 diabetes

    Journal of diabetes and its complications

  3. Testosterone was not clearly linked with cognitive function in humans.

    “These associations were not seen in women.”

    Humansfemalesn = 1,349

    Low Serum Testosterone Concentrations Are Associated With Poor Cognitive Performance in Older Men but Not Women

    Frontiers in aging neuroscience

  4. Testosterone showed no clear effect on cognitive function in humans (community-dwelling postmenopausal women; majority of included observational studies).

    “The majority of studies reported no association between total or free testosterone and cognitive performance.”

    Reviewcommunity-dwelling postmenopausal women; majority of included observational studiesfemales

    Association between testosterone and cognitive performance in postmenopausal women: a systematic review of observational studies

    Climacteric : the journal of the International Menopause Society

Cardiovascular mortality

no changein humans2downin humans1HR 0.95–1.04

3 studies
  1. Testosterone is linked with lower cardiovascular mortality in humans (higher testosterone).

    “Cardiovascular mortality in older men decreased with higher testosterone.”

    Humanshigher testosteronemales

    Age-Dependent Directional Reversal of Total Testosterone Associations across the Phenome in NHANES 2011–2023

    Research SquarePreprint

  2. Testosterone was not clearly linked with cardiovascular mortality in humans (Adjusted for risk factors) (Adjusted HR 1.04, 95% CI 0.84–1.29).

    “CVD deaths (adjusted HR = 1·04, 95% CI 0·84-1·29; P = 0·708)”

    HumansAdjusted for risk factorsMean follow-up of 14.9 yearsmalesn = 1,804

    Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years

    Clinical endocrinology

  3. Testosterone showed no clear effect on cardiovascular mortality in humans (Per 5 nmol/L increase in endogenous testosterone) (HR 0.95, 95% CI 0.83 to 1.08 per 5 nmol/L increase).

    “Analyses of published estimates did not demonstrate associations of endogenous testosterone with CVD deaths or with all-cause mortality.”

    ReviewPer 5 nmol/L increase in endogenous testosteroneAt least 5 years of follow-upmales

    Systematic review and meta-analyses on associations of endogenous testosterone concentration with health outcomes in community-dwelling men

    BMJ open

Mortality

no changein humans3HR 0.9–0.96

3 studies
  1. Testosterone was not clearly linked with mortality in humans (fully adjusted models).

    “In fully adjusted models, no association was seen between SHBG and MACE, or between any hormone or SHBG and all-cause mortality.”

    Humansfully adjusted modelsmedian 4.6 yearsfemalesn = 5,535

    Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial

    The lancet. Healthy longevity

  2. Testosterone was not clearly linked with mortality in humans (Adjusted for risk factors; per 1 SD increase in testosterone) (Adjusted HR 0.90, 95% CI 0.79–1.04 per 1 SD increase).

    “T was not associated with mortality (adjusted HR = 0·90, 95% CI 0·79-1·04; P = 0·164 for every increase in 1 SD of T)”

    HumansAdjusted for risk factors; per 1 SD increase in testosteroneMean follow-up of 14.9 yearsmalesn = 1,804

    Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years

    Clinical endocrinology

  3. Testosterone showed no clear effect on mortality in humans (Per 5 nmol/L increase in endogenous testosterone) (HR 0.96, 95% CI 0.89 to 1.03 per 5 nmol/L increase).

    “no significant effect of a 5 nmol/L increase in testosterone on the risk of all-cause mortality (HR=0.96, 95% CI 0.89 to 1.03)”

    ReviewPer 5 nmol/L increase in endogenous testosteroneAt least 5 years of follow-upmalesn = 20,180

    Systematic review and meta-analyses on associations of endogenous testosterone concentration with health outcomes in community-dwelling men

    BMJ open

Sarcopenia

mediatesin humans2

2 studies
  1. Testosterone is linked with sarcopenia in humans (association with outdoor light exposure) (6.82% for TSO; 5.14% for OLI).

    “A considerable part of these relationships was explained by vitamin D (9.49% for TSO; 8.44% for OLI) and testosterone (6.82% for TSO; 5.14% for OLI).”

    Humansassociation with outdoor light exposure

    Associations between outdoor light exposure and low muscle mass: An NHANES 2011 to 2014 analysis

    Medicine

  2. Testosterone is linked with sarcopenia in humans (sedentary time and sarcopenia risk) (8.56% mediation).

    “Furthermore, SII, 25(OH)D, and testosterone showed a significant mediation in the association between sedentary time and sarcopenia risk, with a mediation effect of 3.39 %, 10.3 %, and 8.56 %, respectively.”

    Humanssedentary time and sarcopenia riskn = 9,902

    The association between sedentary lifestyle and the prevalence of sarcopenia with the mediation role of systematic inflammation index, 25-hydroxyvitamin D, and testosterone: A nationwide cross-sectional study

    Clinical nutrition ESPEN

More on Sarcopenia

Frailty

no changein humans1no changein mice1

2 studies
  1. Testosterone was not clearly linked with frailty in humans (prostate cancer patients under androgen deprivation therapy) (p = 0.60).

    “There were significant relationships between frailty syndrome and the systemic concentration of androstenedione (p = 0.01), but not the concentration of testosterone (p = 0.60) or DHEA (p = 0.42).”

    Humansprostate cancer patients under androgen deprivation therapyplasmamales

    Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy

    Biomolecules

  2. Testosterone showed no clear effect on frailty in mice (p = 0.357).

    “Age predicted frailty (p < 0.0001), but serum testosterone did not (p = 0.357).”

    Animalsmales

    Serum testosterone concentrations are not associated with frailty in naturally ageing and testosterone-deficient older C57Bl/6 mice

    Mechanisms of ageing and development

Sexual function

upin humans1

1 study
  1. Testosterone improves sexual function in humans (Physiologic endogenous testosterone levels).

    “Physiologic testosterone levels contribute to bone maintenance, muscle mass, metabolic homeostasis, endothelial function, cognition, mood regulation, sexual function, and reproductive physiology.”

    ReviewPhysiologic endogenous testosterone levelsfemales

    Beyond libido: the multifaceted role of testosterone in women

    Sexual medicine reviews

Endothelial function

upin humans1

1 study
  1. Testosterone improves endothelial function in humans (Physiologic endogenous testosterone levels).

    “Physiologic testosterone levels contribute to bone maintenance, muscle mass, metabolic homeostasis, endothelial function, cognition, mood regulation, sexual function, and reproductive physiology.”

    ReviewPhysiologic endogenous testosterone levelsendotheliumfemales

    Beyond libido: the multifaceted role of testosterone in women

    Sexual medicine reviews

Bone maintenance

upin humans1

1 study
  1. Testosterone improves bone maintenance in humans (Physiologic endogenous testosterone levels).

    “Physiologic testosterone levels contribute to bone maintenance, muscle mass, metabolic homeostasis, endothelial function, cognition, mood regulation, sexual function, and reproductive physiology.”

    ReviewPhysiologic endogenous testosterone levelsbonefemales

    Beyond libido: the multifaceted role of testosterone in women

    Sexual medicine reviews

Stroke

mediatesin humans1

1 study
  1. Testosterone is linked with stroke in humans (association between sex (women versus men) and risk of stroke) (indirect effect 2.48 (95% CI, 1.27-6.17)).

    “indirect effects were 2.48 (95% CI, 1.27-6.17) and 2.90 (95% CI, 1.67-6.35) for total testosterone and dihydrotestosterone, respectively.”

    Humansassociation between sex (women versus men) and risk of strokemedian follow-up of 8.6 yearsn = 1,970

    Do Androgens and Sex Hormone-Binding Globulin Mediate Sex Differences in the Risk of Stroke and Myocardial Infarction? The KORA Study

    Journal of the American Heart Association

More on Stroke

Measured GFR decline

no changein humans1

1 study
  1. Testosterone was not clearly linked with measured GFR decline in humans (multivariable-adjusted linear mixed model) (-0.02 [-0.04 to 0.01] ml/min per 1.73 m2 per year per nmol/L).

    “Neither TT, FT, nor SHBG were associated with mGFR decline in the multivariable-adjusted linear mixed model analyses”

    Humansmultivariable-adjusted linear mixed modelmedian follow-up of 10.9 yearsmalesn = 800

    The Renal Iohexol Clearance Survey examined whether testosterone is a risk factor for age-related measured glomerular filtration rate decline in males

    Kidney international

Bone mineral density

mediatesin humans1

1 study
  1. Testosterone mediates bone mineral density in humans (-1.18 mg/cm2, 95% CI: -2.68, -0.13).

    “In men, an ILI-associated increase of 11% in total testosterone mediated a decline of hip BMD (-1.18 mg/cm2, 95% CI: -2.68, -0.13).”

    Human trial4 yearsmales

    Sex Hormones Mediate Intensive Lifestyle Intervention-Induced Bone Mineral Density Changes: Look AHEAD Sex Hormone Study

    The Journal of clinical endocrinology and metabolism

More on Bone mineral density

Bone mineral density

no changein humans1

1 study
  1. Testosterone showed no clear effect on bone mineral density in humans (between baseline T < 264 ng/dl and ≥ 264 ng/dl groups during testosterone therapy).

    “No significant differences in BMD and bone turnover markers were observed.”

    Human trialbetween baseline T < 264 ng/dl and ≥ 264 ng/dl groups during testosterone therapy18 monthsmales

    Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy

    Frontiers in endocrinology

Fasting blood glucose

downin humans1

1 study
  1. Testosterone decreases fasting blood glucose in humans (testosterone therapy in men with baseline T ≥ 264 ng/dl vs < 264 ng/dl) (-4.2 ± 31.9 vs. 13.0 ± 57.3%).

    “fasting glucose at 18 months (-4.2 ± 31.9 vs. 13.0 ± 57.3%; p = 0.040)”

    Human trialtestosterone therapy in men with baseline T ≥ 264 ng/dl vs < 264 ng/dl18 monthsmales

    Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy

    Frontiers in endocrinology

More on Fasting blood glucose

Glycated hemoglobin

downin humans1

1 study
  1. Testosterone decreases glycated hemoglobin in humans (testosterone therapy in men with baseline T ≥ 264 ng/dl vs < 264 ng/dl) (-3.1 ± 9.2 vs. 3.2 ± 13.9%).

    “Men with T ≥ 264 ng/dl showed significant decreases in HbA1c at 12 months (-3.1 ± 9.2 vs. 3.2 ± 13.9%; p = 0.005)”

    Human trialtestosterone therapy in men with baseline T ≥ 264 ng/dl vs < 264 ng/dl12 monthsmales

    Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy

    Frontiers in endocrinology

More on Glycated hemoglobin

Total fat-free mass

upin humans1

1 study
  1. Testosterone increases total fat-free mass in humans (testosterone therapy in men with baseline T < 264 ng/dl vs ≥ 264 ng/dl) (4.2 ± 4.1 vs. 2.7 ± 3.8%).

    “Men with T < 264 ng/dl showed greater increases in total fat-free mass (FFM) at 18 months compared to those with T ≥ 264 ng/dl (4.2 ± 4.1 vs. 2.7 ± 3.8%; p = 0.047)”

    Human trialtestosterone therapy in men with baseline T < 264 ng/dl vs ≥ 264 ng/dl18 monthsmales

    Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy

    Frontiers in endocrinology

All 39

Upstream

31

Age

downin humans6downin rats2no changein dogs1no changein humans1

10 studies
  1. Age decreases testosterone in humans.

    “salivary T and DHEA show specific diurnal rhythms, significant alternations in early morning and pronouncedly decline with age.”

    Human trialsalivamales

    Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

  2. Age is linked with lower testosterone in humans (0.021 ng/mL per year (p<0.001)).

    “showing a significant linear decline of approximately 0.021 ng/mL per year (p<0.001)”

    Humansserummalesn = 27,687

    Age-Related Testosterone Decline and Metabolic Determinants in 27,687 Korean Men Aged ≥40 Years: A Nationwide Population-Based Study

    The world journal of men's health

  3. Age is linked with lower testosterone in humans (0.56 nmol/L vs 0.42 nmol/L, p = 0.001).

    “Median testosterone concentrations declined between the ages of 40-44 and 55-59 years (median (interdecile range) 0.56 (0.29-1.01) nmol/L vs 0.42 (0.21-0.79) nmol/L, p = 0.001 adjusted for BMI and smoking)”

    Humansfemales

    Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study

    EBioMedicine

  4. Age was not clearly linked with testosterone in humans.

    “On multivariable-adjusted panel regression analysis, age was not significantly associated with testosterone decline”

    Humansmalesn = 625

    Association between comorbidities and longitudinal changes in total testosterone among men from the Baltimore Longitudinal Study of Aging

    The journal of sexual medicine

  5. Age is linked with lower testosterone in both sexes across adulthood.

    “A4 and T declined with age”

    Humansin both sexes across adulthoodserumn = 590

    Sex Differences in 11-Oxygenated Androgen Patterns Across Adulthood

    The Journal of clinical endocrinology and metabolism

  6. Age is linked with lower testosterone in humans (r range: -0.19 to -0.41).

    “Both DHEA (r range: -0.33 to -0.49) and testosterone (r range: -0.19 to -0.41) were inversely associated with age.”

    Humansmalesn = 57

    Anabolic hormone profiles in elite military men: Robust associations with age, stress, and fatigue

    Steroids

  7. Age decreases testosterone in rats (22-month-old versus 5-month-old male rats).

    “As expected, systemic T levels decreased with age.”

    Animals22-month-old versus 5-month-old male ratsserummales

    Effects of aging on testosterone and androgen receptors in the mesocorticolimbic system of male rats

    Hormones and behavior

  8. Age decreases testosterone in rats (aging rats (24 months) compared with youth controls).

    “Compared with the youth controls, telomerase activity in the testis, testosterone levels, expression of AR, and expression of antiapoptosis factor Bcl-2 protein and mRNA were significantly decreased”

    Animalsaging rats (24 months) compared with youth controlstestismalesn = 8

    Effect of Moxibustion on Testosterone Secretion and Apoptosis of Spermatogenic Cells in Aging Rats

    Evidence-based complementary and alternative medicine : eCAM

  9. Age showed no clear effect on testosterone in dogs.

    “despite the lack of difference between hormone profile of aged dogs”

    Animalsmales

    Effect of senescence on morphological, functional and oxidative features of fresh and cryopreserved canine sperm

    The aging male : the official journal of the International Society for the Study of the Aging Male

  10. Age decreases testosterone in humans.

    “testosterone levels fall with increasing age”

    Reviewmales

    Testosterone replacement therapy for late-onset hypogonadism

    Nature clinical practice. Urology

Type 2 diabetes

downin humans2

2 studies
  1. Type 2 diabetes is linked with lower testosterone in individuals with T2DM vs without T2DM.

    “Mean testosterone was lower in individuals with T2DM than individuals without T2DM.”

    Humansin individuals with T2DM vs without T2DMn = 237

    Comparison of Prevalence of Sarcopenia in Elderly Individuals with and without Type 2 Diabetes Mellitus and its Association with Various Risk Factors

    Journal of Innovative Clinical Trials and Case Reports

  2. Type 2 diabetes decreases testosterone in humans (type 2 diabetes).

    “Type 2 diabetic male patients aged above 30 years showed low testosterone levels which is common in diabetic men and had symptoms of hypogonadism.”

    Reviewtype 2 diabetesmales

    Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications

    Current pharmaceutical design

More on Type 2 diabetes

Late-onset hypogonadism

downin humans2

2 studies
  1. Late-onset hypogonadism decreases testosterone in humans (aging).

    “The core pathophysiological link of LOH lies in the progressive decline of testosterone levels caused by the reduction in the number and functional decline of Leydig cells (LCs).”

    Reviewagingmales

    Restoring testosterone homeostasis: The therapeutic potential of stem Leydig cells for late-onset hypogonadism

    Experimental gerontology

  2. Late-onset hypogonadism decreases testosterone in humans.

    “Aging men with late-onset hypogonadism (LOH) experience physiologic, psychiatric, and sexual symptoms related to a decline in the serum concentration of testosterone with age.”

    Reviewmales

    Late-onset hypogonadism: current methods of clinical diagnosis and treatment in Japan

    Asian journal of andrology

More on Late-onset hypogonadism

Obesity

downin humans2

2 studies
  1. Obesity decreases testosterone in humans.

    “Studies have demonstrated that blood testosterone levels decrease in obese men”

    Reviewmales

    Testosterone and Obesity in an Aging Society

    Biomolecules

  2. Obesity decreases testosterone in humans (metabolic disorders).

    “Metabolic disorders such as obesity and hyperlipidemia accelerate Leydig cell aging, reduce testosterone levels, and contribute to the development of LOH.”

    Reviewmetabolic disordersmales

    Mechanisms of Leydig Cell Aging and Obesity-Related Hypogonadism in Men: A Review

    Medical science monitor : international medical journal of experimental and clinical research

More on Obesity

Polycystic ovary syndrome

upin humans2

2 studies
  1. Polycystic ovary syndrome is linked with higher testosterone in humans (late reproductive years) (p < 0.001, p = 0.001 and p = 0.032).

    “Testosterone, free androgen index, and fasting insulin were higher in PCOS patients than controls (p < 0.001, p = 0.001 and p = 0.032, respectively).”

    Humanslate reproductive yearsfemales

    Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome

    Maturitas

  2. Polycystic ovary syndrome is linked with higher testosterone in humans after 13 years of follow-up.

    “PCOS patients still had higher levels of total testosterone, free androgen index (FAI) and dehydroepiandrosterone sulfate (DHEAS) levels compared to controls.”

    Humansafter 13 years of follow-upfemales

    Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population

    Journal of endocrinological investigation

More on Polycystic ovary syndrome

miR-182-5p

upin chicken cells1

1 study
  1. miR-182-5p increases testosterone in vitro.

    “miR-182-5p overexpression promoted proliferation, inhibited senescence, and elevated testosterone levels in chicken LCs”

    Cellsin vitroLeydig cells

    miR-182-5p regulates proliferation and senescence in chicken Leydig cells via the Wnt/β-catenin pathway by targeting FOXN3

    Poultry science

Cellular senescence

downin reviews1

1 study
  1. Cellular senescence decreases testosterone.

    “LC senescence during aging is key for suppressing testosterone production.”

    Review

    From "Passive Supplementation" to "Active Repair": Melatonin Reshapes the Treatment Paradigm for Late-Onset Hypogonadism by Targeting Leydig Cell Senescence

    Aging cell

More on Cellular senescence

Hypertension

downin rats1

1 study
  1. Hypertension decreases testosterone in aged spontaneously hypertensive rats compared with age-matched WKYs.

    “Aged SHRs had significantly lower serum testosterone levels, higher testicular weight-to-body weight ratios, seminiferous epithelial desquamation and neutrophil infiltration than aged WKYs”

    Animalsin aged spontaneously hypertensive rats compared with age-matched WKYstestismales

    Aging-related severe hypertension causes prostatic gland atrophy and testicular injury in rats

    Scientific reports

More on Hypertension

Prediabetes

no changein humans1

1 study
  1. Prediabetes were not clearly linked with testosterone in humans (prediabetes vs controls) (p = 0.228).

    “No significant difference was observed in testosterone levels between the groups (p = 0.228).”

    Humansprediabetes vs controlsserummales

    Evaluation of Serum Endocan and Testosterone Levels in Male Patients with Prediabetes: A Cross-Sectional Clinical Study

    Journal of clinical medicine

More on Prediabetes

Sleep disorders

downin humans1

1 study
  1. Sleep disorders decrease testosterone in humans.

    “Substantial evidence suggests that sleep disorders may impair testosterone levels”

    Review

    Sleep apnea, heart health and testosterone: unravelling the triad of well-being

    EBioMedicine

More on Sleep disorders

All 31

Associations

148

Cognitive function

upin humans3downin humans2mixedin humans1OR 0.51

6 studies
  1. Testosterone is associated with cognitive function in humans (mild Alzheimer's disease) (r = 0.83, p < 0.001).

    “Changes in salivary T levels were positively (r = 0.83; p < 0.001) and C levels were negatively (r = -0.86; p < 0.001) correlated in the PR, MT and MT + PR groups with changes in MMSE in AD patients.”

    Human trialmild Alzheimer's disease4 monthsmalesn = 26

    Salivary Testosterone and Cortisol Levels in Tunisian Elderly Male Patients With Mild Alzheimer's Disease. Implications of Musical Therapy And/Or Physical Rehabilitation

    Frontiers in physiology

  2. Testosterone is associated with cognitive function in men with one vascular risk factor (P overall =.003, non-linear P =.002).

    “An inverted "U" shaped non-linear relationship was found between testosterone concentration and MMSE score in men with one VRF”

    Humansin men with one vascular risk factorserummalesn = 224

    Sex steroid and cognitive function among community-dwelling older men with or without vascular risk factors: a cross-sectional study

    BMC geriatrics

  3. Testosterone is associated with cognitive function in humans (adjusted odds ratio: 4.72, 95% confidence interval: 1.06-21.00).

    “men with low testosterone concentrations had a significantly greater risk of low cognitive performance than those with high testosterone concentrations (adjusted odds ratio: 4.72, 95% confidence interval: 1.06-21.00)”

    Humansmalesn = 106

    Associations between salivary testosterone levels and cognitive function among 70-year-old Japanese elderly: A cross-sectional analysis of the SONIC study

    Geriatrics & gerontology international

  4. Testosterone is associated with cognitive function in adjusted group (OR = 0.51; 95%CI = 0.27-0.95).

    “higher concentrations of total testosterone were associated with better performance on CERAD test (OR = 0.51; 95%CI = 0.27-0.95) and DSST (OR = 0.54; 95%CI = 0.30-0.99) in adjusted group”

    Humansin adjusted groupmalesn = 1,303

    Low Serum Testosterone Concentrations Are Associated With Poor Cognitive Performance in Older Men but Not Women

    Frontiers in aging neuroscience

  5. Testosterone is associated with cognitive function in humans.

    “Visuospatial abilities showed the most consistent associations with testosterone”

    Reviewmales

    Endogenous androgens, physical and cognitive function in healthy midlife men: A systematic review

    Mechanisms of ageing and development

  6. Testosterone is associated with cognitive function in humans (healthy).

    “low endogenous testosterone levels were associated with poor cognitive performance in healthy elderly men.”

    Reviewhealthymales

    A Review on the Effects of Testosterone Supplementation in Hypogonadal Men with Cognitive Impairment

    Current drug targets

Mortality

downin humans4upin humans2HR 0.892–0.97

6 studies
  1. Testosterone is linked with a lower risk of mortality in humans (chronic spinal cord injury) (HR 0.97, 95% CI 0.95-0.98, p = 0.0139).

    “In fully adjusted Cox models, lower cFT independently predicted mortality (HR 0.97 per pg/mL increase; 95% CI 0.95-0.98; p = 0.0139).”

    Humanschronic spinal cord injurymedian follow-up 62 monthsmalesn = 152

    Low Free Testosterone Is Independently Associated With Long-Term Mortality in Men With Chronic Spinal Cord Injury

    Andrology

  2. Testosterone is linked with a lower risk of mortality in humans (HR 0.892, 95% CI 0.830-0.959).

    “Higher testosterone levels were associated with lower risks of all-cause mortality (hazard ratio (HR) 0.892, 95% confidence interval (CI) 0.830-0.959; P = 0.002)”

    Humansmales

    The role of frailty in the association between testosterone levels and mortality risk in older men

    Maturitas

  3. Testosterone is associated with mortality in humans (baseline testosterone <7.4 nmol/L (<213 ng/dL)).

    “men with baseline testosterone concentrations below 7.4 nmol/L (<213 ng/dL), LH concentrations above 10 IU/L, or estradiol concentrations below 5.1 pmol/L had higher all-cause mortality”

    Humansbaseline testosterone <7.4 nmol/L (<213 ng/dL)males

    Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men : Individual Participant Data Meta-analyses

    Annals of internal medicine

  4. Testosterone is associated with mortality in humans.

    “Analysis of all-cause mortality-which included deaths from any known disease-also revealed greater general risk for those with lower testosterone levels.”

    Humansmalesn = 10,225

    Lower testosterone levels are associated with higher risk of death in men

    Evolution, medicine, and public health

  5. Testosterone is associated with mortality in humans.

    “lower endogenous testosterone concentrations were associated with higher risk of all-cause mortality”

    Reviewmales

    Endogenous Testosterone, Testosterone Treatment, and Cardiovascular Health Outcomes in Men

    The Journal of clinical endocrinology and metabolism

  6. Testosterone is associated with mortality in men.

    “Mortality and incident coronary artery disease are inversely associated with serum T concentrations”

    Reviewin menmales

    Testosterone therapy and cardiovascular risk: advances and controversies

    Mayo Clinic proceedings

Age

downin humans2downin E. maximus1mixedin humans1downin mice1

5 studies
  1. Age is associated with testosterone in humans (infertility) (r = −0.44; R2 = 0.19).

    “Age correlated inversely with testosterone (r = −0.44, R2 = 0.19; p < 0.001).”

    Humansinfertilitymalesn = 293

    Advancing Age and Dyslipidemia Are Independently Associated with Hypogonadism in Infertile Men: Evidence from Lipoprotein Phenotypes and Serum Testosterone Levels-Cross- Sectional Study

    Frontiers in aging

  2. Age is associated with testosterone in humans.

    “Application of the method showed sex and age effects across the lifespan for both allopregnanolone and testosterone”

    Humansserum

    Age and sex effects of a validated LC-MS/MS method for the simultaneous quantification of testosterone, allopregnanolone, and its isomers in human serum

    Scientific reports

  3. Age is associated with testosterone in humans (-14.2% (20.8 vs. 17.8 nmol/L)).

    “T levels decreased by 14.2% (20.8 nmol/L vs. 17.8 nmol/L)”

    Humanslongitudinal change over a mean of 12 years in healthy men aged 24–46 at baseline; adjusted for confoundersserummean 12 yearsmalesn = 691

    Early Decline of Androgen Levels in Healthy Adult Men: An Effect of Aging Per Se? A Prospective Cohort Study

    The Journal of clinical endocrinology and metabolism

  4. Age is associated with testosterone in E. maximus (sexually mature bulls).

    “Testosterone decreased with age in sexually mature bulls”

    Animalssexually mature bullsmales

    Characterization of Longitudinal Testosterone, Cortisol, and Musth in Male Asian Elephants (Elephas maximus), Effects of Aging, and Adrenal Responses to Social Changes and Health Events

    Animals : an open access journal from MDPI

  5. Testosterone is associated with age in mice (aged male mice).

    “Brain testosterone levels were negatively correlated with age in aged males but not females.”

    Animalsaged male micebrainmales

    In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain

    GeroScience

Sarcopenia

downin humans3upin humans2OR 0.95–1.57

5 studies
  1. Testosterone is associated with sarcopenia in humans (Low versus medium testosterone levels) (OR 1.57, 95% CI 1.03–2.40).

    “older men in the low-testosterone group exhibited an increased risk of sarcopenia (OR=1.57, 95%CI:1.03-2.40, P=0.034).”

    HumansLow versus medium testosterone levelsmalesn = 2,240

    Association between sex hormone levels and sarcopenia risk among older adults over 65 years old in longevity areas of China

    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

  2. Sarcopenia is associated with testosterone in patients with sarcopenia compared with non-sarcopenia (369 vs. 497.5 ng/ml, p = 0.03).

    “The non-sarcopenia group had significantly larger PV (40 vs. 20 ml, p < 0.01) and higher testosterone levels (497.5 vs. 369 ng/ml, p = 0.03) compared with the sarcopenia group”

    Humansin patients with sarcopenia compared with non-sarcopeniamalesn = 59

    Screening tool for sarcopenia (SARC-F) predicts unsatisfactory medical treatment of lower urinary tract symptoms in elderly men aged 75 years or older: a preliminary observational study

    International urology and nephrology

  3. Testosterone is associated with sarcopenia in humans (OR 0.95, 95% CI 0.89-1.00).

    “Continuous FT levels was positively associated with the prevalence of sarcopenia in men (odds ratio [OR]=0.95; 95% confidence interval [CI]=0.89-1.00)”

    Humansmalesn = 1,879

    Sex-Specific Differences in the Effect of Free Testosterone on Sarcopenia Components in Older Adults

    Frontiers in endocrinology

  4. Testosterone is associated with sarcopenia in humans (EWGSOP2 definition).

    “lower of diastolic blood pressure, HbA1c, urea, glucose, total bilirubin, and testosterone in women only”

    HumansEWGSOP2 definitionwomens

    Biomarkers Profile of People With Sarcopenia: A Cross-sectional Analysis From UK Biobank

    Journal of the American Medical Directors Association

  5. Testosterone is associated with sarcopenia in chronic liver disease.

    “Low testosterone levels have been associated with sarcopenia, reduced body lean mass, decreased bone mineral density and frailty”

    Reviewin chronic liver disease

    The association of testosterone with sarcopenia and frailty in chronic liver disease

    European journal of clinical investigation

More on Sarcopenia

Cardiovascular disease

upin humans2downin humans2

4 studies
  1. Cardiovascular disease is associated with testosterone in humans.

    “Men reporting cardiovascular disease or currently taking medication for depression had lower age-adjusted Sal-T”

    Humansmales

    Salivary Testosterone Levels and Health Status in Men and Women in the British General Population: Findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

    The Journal of clinical endocrinology and metabolism

  2. Testosterone is associated with cardiovascular disease in humans.

    “Decreased testosterone level is associated with a range of systemic diseases and comorbidities, including cardiovascular disease, cognitive decline, depression, osteoporosis, frailty, increased body fat, and metabolic syndrome.”

    Review

    Testicular aging: mechanism, management and future therapy

    Experimental cell research

  3. Testosterone is associated with cardiovascular disease in humans (Klinefelter syndrome and older men).

    “low endogenous serum T appears to be associated with higher risk of cardiovascular disease and overall mortality in certain populations such as Klinefelter syndrome and older men”

    ReviewKlinefelter syndrome and older menserum

    Conclusions about testosterone therapy and cardiovascular risk

    Asian journal of andrology

  4. Testosterone is associated with cardiovascular disease in humans.

    “studies reporting a significant association of high levels of testosterone with a reduced risk of CVD events in original prospective studies and meta-analyses of cross-sectional and prospective studies seems to be more consistent”

    Review

    Testosterone replacement therapy and the heart: friend, foe or bystander?

    Translational andrology and urology

More on Cardiovascular disease

Osteoporosis

upin humans2downin humans1

3 studies
  1. Testosterone predicts osteoporosis in humans (p < 0.05).

    “Older age, lower BMI, elevated ALP, lower testosterone, and elevated lipoprotein(a) levels were identified as independent predictors for osteoporosis (p < 0.05 for all).”

    Humansfemalesn = 1,375

    Analysis of Factors Influencing Bone Mineral Density in Postmenopausal Women: A Cross-Sectional Study and Implications for Nursing Practice

    Clinical and Experimental Obstetrics & Gynecology

  2. Testosterone is associated with osteoporosis in humans (p-value < 0.001).

    “There was a significant correlation between serum testosterone levels and the severity of osteoporosis according to Singh index grade among older men (p-value < 0.001).”

    Humansplasma-serummales

    Relationship Between Serum Testosterone And Osteoporosis In Older Men: A Cross-Sectional Study

    THE NEW ARMENIAN MEDICAL JOURNAL

  3. Testosterone is associated with osteoporosis in humans (p = 0.019).

    “decreased testosterone, COPD and BPH were significantly associated with male osteoporosis.”

    Humansmalesn = 408

    The prevalence of osteoporosis and its association with serum testosterone and serum vitamin D in the elderly male population: A cross-sectional study

    Medical journal, Armed Forces India

More on Osteoporosis

Type 2 diabetes

downin humans2no changein humans1RR 1.11

3 studies
  1. Testosterone is linked with a lower risk of type 2 diabetes in humans (OR 0.92, 95% CI 0.87–0.97, p = 0.001).

    “An independent inverse relationship between serum testosterone concentration and 5-year incident T2D was observed (OR = 0.92, 95% CI = [0.87, 0.97], p = 0.001).”

    Humans5-yearmalesn = 1,299

    Higher Serum Testosterone Protects Against the Development of Type 2 Diabetes in Middle-Aged but Not Older Men

    Diabetes, obesity & metabolism

  2. Testosterone is associated with type 2 diabetes in humans (RR 1.11, 95% CI 0.73–1.50).

    “testosterone was not significantly associated with incident T2D (RR 1.11, 95% CI 0.73–1.50).”

    Reviewfemales

    Endogenous Sex Hormones (FSH, Oestradiol, Testosterone and SHBG) and Type 2 Diabetes Risk in Postmenopausal Women: A Systematic Review and Meta-Analysis

    Endocrines

  3. Testosterone predicts type 2 diabetes in men.

    “low testosterone levels predict development of type 2 diabetes mellitus, metabolic syndrome, and survival.”

    Reviewin menmales

    Testosterone replacement in men

    Current opinion in endocrinology, diabetes, and obesity

More on Type 2 diabetes

Body mass index

downin humans3

3 studies
  1. Body mass index is associated with testosterone in humans.

    “higher BMI, fasting glucose, and triglyceride levels were independently associated with lower testosterone”

    Humansserummalesn = 27,687

    Age-Related Testosterone Decline and Metabolic Determinants in 27,687 Korean Men Aged ≥40 Years: A Nationwide Population-Based Study

    The world journal of men's health

  2. Testosterone is associated with body mass index in humans.

    “showed a strong independent negative association with body mass index (BMI) in multivariable analysis.”

    Humansmales

    Salivary Testosterone Levels and Health Status in Men and Women in the British General Population: Findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

    The Journal of clinical endocrinology and metabolism

  3. Testosterone is associated with body mass index in humans (Testicular cancer survivors treated with cisplatin-based chemotherapy).

    “Lower testosterone levels were associated with a higher BMI, fat mass, and abdominal fat distribution in TCS.”

    HumansTesticular cancer survivors treated with cisplatin-based chemotherapymalesn = 50

    Taste and smell function in testicular cancer survivors treated with cisplatin-based chemotherapy in relation to dietary intake, food preference, and body composition

    Appetite

Smoking

upin humans2downin humans1

3 studies
  1. Smoking is associated with testosterone in humans.

    “Total testosterone levels were modestly correlated with directly measured free testosterone, estradiol, estrone, DHT, and SHBG, and weakly negatively associated with body mass index and smoking.”

    Humansserummalesn = 477

    Longitudinal Changes in Sex Hormones in a Population of Older Community-dwelling Men

    The Journal of clinical endocrinology and metabolism

  2. Smoking is associated with testosterone in humans (Past and current smokers compared with never smokers during perimenopause).

    “Past and current smokers also had higher testosterone levels compared to never smokers.”

    HumansPast and current smokers compared with never smokers during perimenopausefemalesn = 50

    Testosterone and depressive symptoms during the late menopause transition

    Biology of sex differences

  3. Smoking is associated with testosterone in humans.

    “there were no age-independent associations with health-related factors or specific heath conditions with the exception of higher Sal-T in smokers.”

    Humansfemales

    Salivary Testosterone Levels and Health Status in Men and Women in the British General Population: Findings from the Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)

    The Journal of clinical endocrinology and metabolism

More on Smoking

Frailty

downin humans1upin humans1downin reviews1OR 0.391–1.37

3 studies
  1. Testosterone is associated with frailty in humans (elderly men presenting with LUTS) (OR=0.391, p=0.043).

    “serum testosterone were significant predictors (odds ratio [OR]=4.679, p=0.29; OR=0.391, p=0.043, respectively).”

    Humanselderly men presenting with LUTSmalesn = 62

    Identification of Correlation Between Frailty and Lower Urinary Tract Symptoms in Elderly Male Using Korean-FRAIL Scale

    The world journal of men's health

  2. Testosterone is associated with frailty.

    “Currently, significant correlations between testosterone and frailty in men have been confirmed by numerous cross-sectional studies.”

    Reviewmales

    Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review

    Journal of clinical medicine

  3. Testosterone is associated with frailty in humans (OR = 1.37 [95% CI 1.09, 1.72]).

    “meta-analysis revealed a significant association between TT and frailty in men (OR = 1.37 [95% CI 1.09, 1.72]) not women”

    Reviewmales

    Frailty and testosterone level in older adults: a systematic review and meta-analysis

    European geriatric medicine

Muscle strength

upin humans2downin humans1

3 studies
  1. Testosterone is associated with muscle strength in humans.

    “Increases in leg-press strength and stair-climbing power were associated with changes in testosterone levels and muscle mass”

    Human trialmales

    Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation

    The journals of gerontology. Series A, Biological sciences and medical sciences

  2. Testosterone is associated with muscle strength in humans.

    “Significant positive correlation was observed between changes in serum T with muscle mass, strength, and hemoglobin but not with PSA across the three time-points.”

    Humansmuscle5 yearsmales

    Temporal Trend in Androgen Status and Androgen-Sensitive Outcomes in Older Men

    The Journal of clinical endocrinology and metabolism

  3. Testosterone is associated with muscle strength in humans (baseline serum total testosterone metaregression) (β = -0.004, p = 0.002).

    “A metaregression revealed that baseline serum total testosterone was associated with muscle strength improvement (β = -0.004, p = 0.002).”

    Reviewbaseline serum total testosterone metaregressionmalesn = 2,043

    Effects of Testosterone Replacement Therapy on Muscle Strength in Older Men with Low to Low-Normal Testosterone Levels: A Systematic Review and Meta-Analysis

    Gerontology

Telomere length

downin humans1

1 study
  1. Testosterone is associated with telomere length.

    “Among males, baseline testosterone concentrations were strongly negatively correlated with the fold-change of TL after BCG vaccination ( C).”

    Human trial3 months

    Long-term effects of BCG vaccination on telomere length and telomerase activity

    iScience

  2. Testosterone is associated with telomere length in humans (higher pre-vaccination testosterone; after BCG vaccination).

    “Higher pre-vaccination testosterone levels were associated with greater telomere loss in males.”

    Human trialhigher pre-vaccination testosterone; after BCG vaccinationimmune cellsthree monthsmales

    Long-term effects of BCG vaccination on telomere length and telomerase activity

    iScience

More on Telomere length

Physical activity

upin humans1

1 study
  1. Physical activity is associated with testosterone in humans (r = 0.40, p<0.01).

    “In addition, the percentage changes in serum testosterone levels were significantly correlated with that in the total number of steps taken per day (r = 0.40, p<0.01).”

    Human trial12 weeksmalesn = 41

    Increased physical activity has a greater effect than reduced energy intake on lifestyle modification-induced increases in testosterone

    Journal of clinical biochemistry and nutrition

  2. Physical activity is associated with testosterone in humans.

    “We found a significant positive correlation between the changes in serum testosterone levels and the number of steps.”

    Human trial12 weeksmalesn = 41

    Increased physical activity has a greater effect than reduced energy intake on lifestyle modification-induced increases in testosterone

    Journal of clinical biochemistry and nutrition

More on Physical activity

Metformin

downin humans1

1 study
  1. Metformin is associated with testosterone in humans (PCOS; before-and-after comparison without an untreated comparator) (0.81 ± 0.07 to 0.73 ± 0.08 ng/mL).

    “Testosterone declined significantly from 0.81 ± 0.07 to 0.73 ± 0.08 ng/mL (p < 0.001)”

    Human trialPCOS; before-and-after comparison without an untreated comparatormaximum of 2.55–3.0 g/day6 monthsfemalesn = 120

    Impact of Metformin on Gonadotropic Hormones, Prolactin Fractions, and Androgen Profile in Women with Polycystic Ovary Syndrome and Prediabetes: A Prospective Comparative Study

    Pathophysiology : the official journal of the International Society for Pathophysiology

More on Metformin

Prevotellaceae

upin humans1

1 study
  1. Testosterone is associated with Prevotellaceae in humans.

    “higher salivary testosterone levels were linked to higher Prevotellaceae taxa and Succinivibrio levels”

    Human trialgut microbiomemalesn = 79

    Exercise, APOE Genotype, and Testosterone Modulate Gut Microbiome-Cognition Associations in Prostate Cancer Survivors

    Genes

More on Prevotellaceae

All 148

Funding

24 grants since 2017

US Department of Veterans AffairsNational Institute on Aging$16.4MJapan Society for the Promotion of Science¥20.9M

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human observational studies associate testosterone with mortality, bone mineral density, and lean mass in men; lower levels are associated with sarcopenia. Human trials report increases with exercise but decreases with exercise in women with polycystic ovary syndrome. In male rats, resveratrol and melatonin do not alter age-related testosterone decline.

  2. Summary rewritten as its findings changed.

    As it read before

    A longitudinal study reports declining testosterone with age in healthy older men, while human observational studies associate lower levels with sarcopenia and cognitive impairment in men. A human preprint links testosterone to higher mortality risk given men's health and inflammation; a mouse study reports no effect of testosterone on frailty in males.

  3. Summary rewritten as its findings changed.

    As it read before

    Human studies associate higher testosterone with lower mortality, less cognitive impairment and greater grip strength in men, while a study in women finds no mortality association. Lower levels are associated with sarcopenia in men; higher levels correlate with poorer verbal fluency and visuoconstruction in women.

  4. Summary rewritten as its findings changed.

    As it read before

    A human preprint links testosterone to declining cerebellar volumes in females; another links it to an ADHD brain functional profile. A review preprint describes testosterone reductions with weight loss in humans.

  5. Summary written from the findings.

Latest

Diagnostics

DNA variants relevant to menopause show varied health links

An observational genomic analysis linked 25 of 31 menopause-relevant DNA variants to at least one trait, with associations spanning up to 16 traits per variant.An observational genomic analysis linked 25 of 31 menopause-relevant DNA variants to at least one trait, with associations spanning up to 16 traits per variant.

Genetic association studyMenopause
PNAS

Adding a brain RNA improved sperm quality in male mice

In an animal experiment, adding Synage to a brain region increased testosterone, sperm counts and forward sperm movement in 12-month-old mice.In an animal experiment, adding Synage to a brain region increased testosterone, sperm counts and forward sperm movement in 12-month-old mice.

See all 2,281 papers on testosterone